We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
GE Vernova
GEV
$253B
| $352M | 0.66% |
665,828
+97,926
| +17% | +$40.8M |
|
27
Prologis
PLD
$135B
| $343M | 0.65% |
3,267,250
+40,519
| +1% | +$4.25M |
|
28
Roblox
RBLX
$27B
| $341M | 0.64% |
3,245,338
+1,646,871
| +103% | +$129M |
|
29
Huntington Bancshares
HBAN
$34.1B
| $341M | 0.64% |
20,336,013
+232,528
| +1% | +$3.51M |
|
30
Teradyne
TER
$57B
| $340M | 0.64% |
3,785,067
+1,679,215
| +80% | +$134M |
|
|
31
Gilead Sciences
GILD
$184B
| $330M | 0.62% |
2,980,646
-1,885,664
| -39% | -$201M |
|
32
DexCom
DXCM
$33.9B
| $317M | 0.6% |
3,633,139
+1,638,407
| +82% | +$128M |
|
33
PepsiCo
PEP
$192B
| $313M | 0.59% |
2,367,288
+376,024
| +19% | +$50.7M |
|
34
Veralto
VLTO
$23.9B
| $300M | 0.56% |
2,967,867
-98,643
| -3% | -$9.52M |
|
35
Trane Technologies
TT
$101B
| $286M | 0.54% |
653,965
+9,706
| +2% | +$3.83M |
|
36
Celanese
CE
$4.85B
| $281M | 0.53% |
5,081,458
+3,280,109
| +182% | +$163M |
|
37
Morgan Stanley
MS
$337B
| $278M | 0.52% |
1,970,570
-234,173
| -11% | -$28.8M |
|
|
38
FirstEnergy
FE
$26.7B
| $277M | 0.52% |
6,888,967
+4,578,375
| +198% | +$189M |
|
|
AXON
39
Axon Enterprise
AXON
$49.7B
| $276M | 0.52% |
333,364
+10,157
| +3% | +$6.91M |
|
|
PPL
40
PPL Corp
PPL
$26B
| $274M | 0.52% |
8,074,354
+76,155
| +1% | +$2.65M |
|
41
Evergy
EVRG
$18.8B
| $254M | 0.48% |
3,685,142
+293,564
| +9% | +$19.7M |
|
42
Nutanix
NTNX
$18.9B
| $246M | 0.46% |
3,215,800
+791,822
| +33% | +$57M |
|
43
Quanta Services
PWR
$93.4B
| $245M | 0.46% |
648,915
+108,587
| +20% | +$34.9M |
|
44
Fortinet
FTNT
$122B
| $244M | 0.46% |
2,309,054
+97,941
| +4% | +$9.88M |
|
45
Qualcomm
QCOM
$176B
| $239M | 0.45% |
1,497,611
-724,262
| -33% | -$107M |
|
46
National Grid
NGG
$79.5B
| $238M | 0.45% |
3,245,943
-25,469
| -0.8% | -$1.75M |
|
47
Visa
V
$711B
| $236M | 0.44% |
663,356
+20,830
| +3% | +$7.26M |
|
48
DoorDash
DASH
$101B
| $235M | 0.44% |
953,502
-50,415
| -5% | -$10.1M |
|
49
Bank of America
BAC
$430B
| $233M | 0.44% |
4,932,445
+183,215
| +4% | +$7.71M |
|
50
Palo Alto Networks
PANW
$305B
| $231M | 0.43% |
1,128,314
+103,134
| +10% | +$19.2M |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.